Share ownership control bodies
Pierre Fabre Foundation
The Pierre Fabre Foundation is the Group's majority shareholder. Since the Foundation is dedicated first and foremost to its public-interest mission, it delegates supervision of Group management to its subsidiary, Pierre Fabre Participations.
Pierre Fabre Participations
This controlling company approves the Group's strategy, appoints its main executives and ensures that the continuity mission set out by Mr. Pierre Fabre himself is observed:
- Ensuring the Group's independence
- Maintaining both areas of activity (Pharmaceuticals and Dermo-Cosmetics)
- Investing heavily in R&D
- Prioritizing long-term goals rather than short-term financial results
- Maintaining the Group's footprint in its home region and its culture of corporate social responsibility
- Enabling the Pierre Fabre Foundation to pursue its objectives through a suitable dividend payment policy
Pierre Fabre SA
Pierre Fabre S.A. is the Group's holding company. It establishes the Group's overall strategy, consolidates and coordinates our activities and hosts shared services and support functions. Pierre Fabre Pharmaceuticals and Pierre Fabre Dermo-Cosmetics are the main subsidiaries of Pierre Fabre S.A., respectively in charge of the pharmaceutical and dermo-cosmetics businesses.
Pierre Fabre SA Supervisory Board
The Supervisory Board is chaired by Roch DOLIVEUX. Pierre-Yves REVOL is the Vice-Chairman.
Board members: Dominique BAZY, Jean-Luc BELINGARD, Jean-Jacques BERTRAND, Jean-Laurent BONNAFE, Nathalie DELAPALME, Jacques FABRE, Philippe FAURE, Marie-France MARCHAND-BAYLET, Rachel MAROUANI, Catherine de ROHAN-CHABOT, Marie-Christine ROQUES and Eduardo SANCHIZ
Employee and employee shareholder scheme representatives: Agathe AMARA-COLOMBIE, Christophe LATOUCHE, Claire MEUNIER and Alexandre GIRAUDON.
The Pierre Fabre Supervisory Board has formed three committees:
- The Audit Committee chaired by Dominique BAZY
The main missions of this committee are to examine the accounts and monitor issues concerning the generation and control of accounting and financial information. The Audit Committee is also responsible for checking the effectiveness of the Group's risk management and internal control systems. Its members are: Dominique BAZY, Roch DOLIVEUX, Eric DUCOURNAU, Christophe LATOUCHE and Pierre-Yves REVOL.
- Nomination and Remuneration Committee, chaired by Jean-Jacques BERTRAND
This committee assists the board in selecting its members and corporate executives, and formulates recommendations concerning their remuneration.
Its members are: Jean-Jacques BERTRAND, Eric DUCOURNAU and Pierre-Yves REVOL.
- Strategic Committee chaired by Roch DOLIVEUX
The aim of this committee is to issue opinions on the Group's main strategic choices, in particular in terms of R&D, and on its business development policy, proposed by executive management to the Supervisory Board.
Its members are: Roch DOLIVEUX, Marie-Anne AYMERICH, Dominique BAZY, Jean-Luc BELINGARD, Jean-Jacques BERTRAND, Jean-Laurent BONNAFE, Eric DUCOURNAU, Philippe FAURE, Rachel MAROUANI, Pierre-Yves REVOL and Eduardo SANCHIZ.
The Group's Executive Committee
Eric DUCOURNAU is the Group's CEO. The members of the Executive Committee are:
- Núria PEREZ-CULLELL (CEO, Dermo-Cosmetics Division)
- Jean-Luc LOWINSKI (CEO, Pharmaceuticals Division)
- Eric GOUY (Senior Vice-President, Finance)
- Agnès PARK (Senior Vice-President of Human Resources & Ethics)
- Michaël DANON(Senior Vice-President, Legal, Pharmaceutical & Public Affairs)
- Olivier SIEGLER (Director of the Digital Processes and Organization Corporate Department)
- Marc ALIAS (Director, Corporate Communications)